Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.53K | Sales 2023 | 555 362.17 | Capitalization | 39.72M 25.92M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.66M | Net income 2023 | -20M -13.05M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.8M | Net cash position 2023 | 3.44M 2.25M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |